The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First in-human, phase I study of the safety, tolerability and pharmacokinetics (PK) of BPM31543 (topical calcitriol solution) in adult cancer patients: Preliminary results.
 
Shari Beth Goldfarb
No Relationships to Disclose
 
Janice Stevens
Employment - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
 
Susan Brouwer
Employment - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
 
Ely Benaim
Employment - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
 
Niven R. Narain
Employment - Berg Pharma
Leadership - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
Patents, Royalties, Other Intellectual Property - Berg Pharma
Travel, Accommodations, Expenses - Berg Pharma
 
Rangaprasad Sarangarajan
Employment - Berg Pharma
Leadership - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
Research Funding - Berg Pharma
Patents, Royalties, Other Intellectual Property - Berg Pharma
Travel, Accommodations, Expenses - Berg Pharma
 
Alison Kracunas
Employment - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
 
Joaquin Juan Jimenez
No Relationships to Disclose
 
Viswanath Reddy Belum
No Relationships to Disclose
 
Kathryn Ciccolini
No Relationships to Disclose
 
Danielle Kehn
No Relationships to Disclose
 
Mario E. Lacouture
Honoraria - Advancell; Aveo; Bayer; BIOPHARM; Boehringer Ingelheim; Brickell Biotech; Bristol-Myers Squibb; Clinical Assistance Programs LLC; Clinical Care Options; EMD Serono; Envision Communications; Foamix; Galderma; Genentech/Roche; GlaxoSmithKline; Helsinn Healthcare; Helsinn Healthcare; Medscape; Merck; NeRRe Therapeutics; Novartis; Novocure; Oncology Specialty Group; Pfizer; Pierre Fabre; Threshold Pharmaceuticals
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Brickell Biotech; Bristol-Myers Squibb; EMD Serono; Foamix; Galderma; Genentech/Roche; GlaxoSmithKline; Helsinn Healthcare; Merck; Novartis; Novocure; Pfizer; Pierre Fabre; Threshold Pharmaceuticals
Research Funding - Berg Pharma (Inst)